LianBio (LIAN) Competitors $0.06 +0.00 (+3.77%) As of 08/5/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendFDA EventsInsider TradesSEC FilingsTrendsBuy This Stock LIAN vs. ALTS, IKT, GNLX, LIMN, CGEN, MCRB, SPRO, BHST, IMRX, and FTLFShould you be buying LianBio stock or one of its competitors? The main competitors of LianBio include ALT5 Sigma (ALTS), Inhibikase Therapeutics (IKT), Genelux (GNLX), Liminatus Pharma (LIMN), Compugen (CGEN), Seres Therapeutics (MCRB), Spero Therapeutics (SPRO), BioHarvest Sciences (BHST), Immuneering (IMRX), and FitLife Brands (FTLF). These companies are all part of the "pharmaceutical products" industry. LianBio vs. Its Competitors ALT5 Sigma Inhibikase Therapeutics Genelux Liminatus Pharma Compugen Seres Therapeutics Spero Therapeutics BioHarvest Sciences Immuneering FitLife Brands ALT5 Sigma (NASDAQ:ALTS) and LianBio (NASDAQ:LIAN) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, profitability, valuation and earnings. Which has preferable earnings & valuation, ALTS or LIAN? ALT5 Sigma has higher revenue and earnings than LianBio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioALT5 Sigma$12.53M10.88-$6.24MN/AN/ALianBioN/AN/A-$110.29M-$0.81-0.07 Does the media refer more to ALTS or LIAN? In the previous week, ALT5 Sigma's average media sentiment score of 0.00 equaled LianBio'saverage media sentiment score. Company Overall Sentiment ALT5 Sigma Neutral LianBio Neutral Is ALTS or LIAN more profitable? LianBio has a net margin of 0.00% compared to ALT5 Sigma's net margin of -38.58%. LianBio's return on equity of -33.17% beat ALT5 Sigma's return on equity.Company Net Margins Return on Equity Return on Assets ALT5 Sigma-38.58% -113.79% -8.96% LianBio N/A -33.17%-30.19% Which has more volatility & risk, ALTS or LIAN? ALT5 Sigma has a beta of 2.17, meaning that its share price is 117% more volatile than the S&P 500. Comparatively, LianBio has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Do institutionals and insiders believe in ALTS or LIAN? 6.3% of ALT5 Sigma shares are held by institutional investors. Comparatively, 74.8% of LianBio shares are held by institutional investors. 4.9% of ALT5 Sigma shares are held by insiders. Comparatively, 7.6% of LianBio shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryALT5 Sigma and LianBio tied by winning 4 of the 8 factors compared between the two stocks. Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LIAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIAN vs. The Competition Export to ExcelMetricLianBioBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.94M$136.16M$5.57B$9.47BDividend YieldN/A3.74%4.31%4.13%P/E Ratio-0.073.7429.3723.99Price / SalesN/A4,300.07444.1896.63Price / CashN/A13.1935.8458.51Price / Book0.0239.728.085.58Net Income-$110.29M-$90.99M$3.26B$265.35M7 Day PerformanceN/A0.22%0.45%-0.07%1 Month PerformanceN/A4.15%4.83%1.76%1 Year PerformanceN/A181.71%30.28%25.39% LianBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIANLianBioN/A$0.06+3.8%N/A-81.9%$5.94MN/A-0.07110Gap UpALTSALT5 SigmaN/A$6.73-1.2%N/A+401.5%$137.17M$12.53M0.00170IKTInhibikase Therapeutics1.6839 of 5 stars$1.80+12.5%$6.50+261.1%+32.1%$133.82MN/A-0.676GNLXGenelux1.151 of 5 stars$3.53+0.6%$17.75+402.8%+96.2%$132.54M$10K-4.0110News CoverageUpcoming EarningsLIMNLiminatus PharmaN/A$4.94-2.9%N/AN/A$132.41MN/A0.00N/ACGENCompugen1.6615 of 5 stars$1.46flat$4.00+174.0%-15.1%$130.29M$27.86M-9.1370News CoverageEarnings ReportMCRBSeres Therapeutics3.2845 of 5 stars$14.28-3.4%$73.67+415.9%-31.8%$129.07M$126.32M-3.10330News CoverageSPROSpero Therapeutics3.8487 of 5 stars$2.12-6.2%$5.00+135.8%+78.0%$126.36M$47.98M-1.66150News CoverageHigh Trading VolumeBHSTBioHarvest SciencesN/A$7.50-2.2%$13.67+82.2%N/A$125.98M$25.19M-15.00N/ANews CoverageUpcoming EarningsIMRXImmuneering3.4638 of 5 stars$3.57+4.1%$13.25+271.1%+183.9%$123.43M$320K-1.8260News CoveragePositive NewsFTLFFitLife Brands3.929 of 5 stars$15.45+18.4%$20.50+32.7%+1.7%$122.55M$64.47M18.3920News CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies ALTS Alternatives IKT Alternatives GNLX Alternatives LIMN Alternatives CGEN Alternatives MCRB Alternatives SPRO Alternatives BHST Alternatives IMRX Alternatives FTLF Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIAN) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
